( W: A( g, h2 X6 K K- s 4 Q1 y, |9 h7 C3 v. l3 U; m- i . T0 I; S! c. T+ H' p7 t7 | ; G' h" N+ I+ v5 Y2 J/ y/ a. b- K( F8 M0 Y4 C! K. C$ w% x
1 w' }6 r2 w# O8 u
* t/ |$ k- f! J' v
" r% f( J' v* I+ Z: e ( M2 ]9 o) L5 z* C* K0 V+ l1 F5 T V6 g. \
% m" ]# G0 g% B) v . G% G b! y' N& q" L1 a" i# G' a. ]8 Q! j# Q. o
6 d3 o0 [3 ?' y
6 e6 W: m( j7 o4 y
, n, k% D4 C+ s t8 a
5 g2 j( ?' H$ N4 {$ f- y
- \. e- F& W/ V4 x
. g8 |/ A ?; {$ |" B" ` 1 @. {2 m" }$ t0 t, D0 \) D 9 C& m) B/ B* P; g + n! H1 z3 v# T9 N( p9 D8 V' K# s: }1 N6 n
7 A8 W2 t- \ r" O& K" M0 k+ Z- n' g
. T% L5 ~9 h+ H: J# }- qTentative Session$ c) H: N! b* z7 t1 w' g
China Classification and Variable Selection . z* v- j* n' t& l) x" W' L% B
(Chair: Yang Li, Renmin University of China) ! w0 w8 c* p' Q. Q5 N Clinical information data mining and application E+ C T5 s9 S% o1 l(Chair: Xiuhua Guo, Capital Medical University), \. _" P( i7 a$ o- R! ~, x
Japan Missing Data in Clinical Trials: Basic Concepts and Practical Issues in Japan) I& g/ `) c. i2 C/ r+ s0 U
(Chair: Hideki Suganami, Ph.D. Kowa Co., Ltd., Satoru Fukinbara, Ph.D. Ono Pharmaceutical Co., Ltd.)4 }* {/ c% U' g( j0 B8 y
* |7 J$ l( Z. E- ]; Y
Design and conduct of clinical trials for preventing missing data ! s2 U, h. \0 V0 n; n# Z(Speaker: Shiro Tanaka, Ph.D.Kyoto University) . q5 |: E- k. d+ {! v7 \0 o$ m( x Some examples of the treatment of missing data in investigator-initiated clinical trials . F, Z$ E' i. F' p+ b# w0 j0 Q(Speaker: Yoichi M. Ito, Ph.D.Hokkaido University) / p( _6 t. X5 M; G: _4 \ Actual practice of handling of missing data in clinical trials 1 Q" C* W% Z' j* p# R8 C2 d
(Speaker: Nobushige Matsuoka, Ph.D., Yoichi Ii, Ph.D., Tamotsu Yoshiyama, M.S., Norisuke Kawai, Ph.D. ,Clinical Statistics, Pfizer Japan Inc.) W$ v) X# d5 k* [9 a3 ~: h7 B z
Survey results from JPMA member companies: Current approach for missing data in pivotal registration trials2 T7 u- } d" o! q! h7 s/ J
(Speaker: Satoru Tsuchiya, M.S. ,Biostatistics group, Data science Dainippon Sumitomo Pharma, Co., Ltd.)6 d- X4 L9 F1 j3 ]9 a
$ ^0 i5 o* H: r2 h# v; H: K$ G
. ]0 d5 S8 H8 U1 a* i* P2 ?# U& H, i2 ?
% y3 ~. t* ?' ^% H" L) g) x* Y
Korea $ X7 I+ ^1 T/ L1 w & J- N, b( i% V1 m 2 F+ E2 T& D. R' {; [* U ' F1 P! k* T: ` + B. S5 B* }7 e n& Z1 A, K+ P/ K: K, ^3 R6 A$ A( s+ W( v
/ b( L$ v1 r6 L2 `0 r
Korea Selected Topics in Biometrics study , N# Q. k0 s# s% p% T(Chair:Hyonggin An, Korea University)- J& {: c. l6 v
Identification of Variant Associated with Disease using Protein Structural Feature-based Prioritization# F6 P2 H: U5 X) e
(Speaker: Tae-Rim Lee,Korea National Open University,Min-Seok Kwon(Seoul National University),Sungho Won(Chung Ang University),Taesung Park(Seoul National University)) 3 [+ w' E T% Q8 l. s3 ^, z& i + j$ s- X3 B3 G K Differential Expression Detection in RNA-seq Data with a Small Number of Replicates * w2 d* Z% U" h! x; g(Speaker: Jungsoo Gim(Seoul National University), Taesung Park(Seoul National University)) , j7 ]- @" h; n9 V Investigation of Relationship between Influenza Occurrence and Climatic Factors in Three Major Regions in Korea using Time Series Analysis; V+ ] j9 E1 d. D4 M
(Speaker: Hyonggin An (Korea University College of Medicine)and Sang-A Cho (National Cancer Center in Korea)) 8 a. g% t# ~' z& D Chair: Jinheum Kim, University of Suwon 4 x% x0 C) a) | W ~, l Additive Hazard Model with Additive Frailty for Semi-Competing Risks Data (Speaker: Yun-Nam Kim (Severance Hospital Clinical Trials Center), Chung Mo Nam(Yonsei University College of Medicine), Yang-Jin Kim(Sookkmyung Women’s University), and Jinheum Kim(University of Suwon))7 S" `5 ^+ f0 g ~2 W
Variable Selection in Competing-Risks Frailty Models using Penalized H-likelihood# W; W: G* G4 A! U4 G
(Speaker: Do Ha (Daegu Haany University) and Youngjo Lee (Seoul National University)), N0 z) ~# d5 x9 X# {
Gene-Gene Interaction Analysis with Survival Phenotype ; C6 g& [) g C8 F (Speaker: Seungyeon Lee (Sejong University), Jin-SeokOh(Sejong University), Min-Seok Kwon(Seoul National University), and Taesung Park(Seoul National University))3 `$ `; \ n$ b' [
Maximally Selected Two-sample Gray Statistics with Competing Risks Data- c; V; x9 Q0 j& `. j; s
(Speaker: Jinheum Kim (University of Suwon), Sook-young Woo(Samsung Advanced Institute of Technology), Seonwoo Kim(Samsung Advanced Institute of Technology)) * Z- `6 M0 T* kSingapore Session title: Likelihood based inference for complex models : @" v y# }- @5 C% F A multiple imputation method for longitudinal data with covariate measurement error under generalized partially linear mixed models ; Z3 \; x4 k9 I `: f7 Z(Speaker: Xiang Liming(Nanyang Technological University))' b; K) @6 j* ~% C; g I! J
Bayesian Empirical Likelihood/ ], ?8 B/ U! z, U" |1 o
(Speaker: Sanjay Chaudhuri(National University of Singapore, Singapore))6 c+ u' w' F$ |( G
Consistent Cross-Validation for Tuning Parameter Selection in High-Dimensional Variable Selection - D+ c0 }* i3 ~(Speaker: Yang Feng(Columbia University))" h2 R! a0 d' y) T
A sign based loss approach to model selection in nonparametric regression * w8 J& K3 h1 [! D1 w( B* k, F(Speaker: Li Jialiang (National University of Singapore, Singapore))9 v: L7 y& B* ~) N- [# a1 f7 c, F: C
Thailand Meta analysis in Clinical Trials1 Z4 j+ ]! L8 P/ j- b, s% r" u/ m
Publication Bias and Sensitivity Analysis for Meta-Analysis of Multi-Arm Trials 6 p+ r/ ?3 R) F+ e. x. H; w/ `(Speaker: Dr. Hathaikan Chootrakool (Suan Dusit Rajabhat University)) ' t; J, s; E# c x Some New Tests for Homogeneity of Relative Risks in Meta-Analysis# ~- W9 f G7 o* f4 z
(Speaker: Assoc. Prof. Dr. Chtwongkasemukiat Viwatwongkasem (Mahidol University)) ) l8 x% w. h( X( a5 Q Application of Network Meta-analysis in Randomized Controlled Trials8 R' q, D* |; F- E
(Speaker: Dr. Ammarin Thakkinstian(Ramathibodi Hospital, Mahidol University)) # m3 y) ^) G7 i# X! U2 ~; T 9 h, W0 K( [0 z$ l& G7 T3 F! l0 t( [
' [* I1 g* H. {" [; G
; u2 ~# Q4 w* `. i
$ M& u# q2 w7 T7 _6 A& }
9 |+ `8 R) d! U3 n( [) D: J
# X) | j9 v C% ~$ @, a" D+ e
) h+ {+ s1 g8 {% w
8 G O5 q7 V7 \7 _ 2 s( [9 {0 o0 J: z/ x. h & U. K- [/ a( B4 `$ ?; u# z